Direct healthcare professional communication with updated information on the risk of diabetic ketoacidosis during treatment with SGLT2 inhibitors (Invokana*, Vokanamet*, Forxiga, Xigduo, Jardiance, Synjardy*)
14.03.2016
more
News and Educations
HALMED and IMROH started formal cooperation in the field of monitoring of drug overdoses
10.03.2016
more
CMDh News – February 2016
07.03.2016
more
Additional guideline concerning the submission of conventional dossiers on medicinal products
02.03.2016
more
CHMP News – February 2016
29.02.2016
more
Beginning of a review of medicines containing dienogest 2 mg and ethinylestradiol 0.03 mg when used for acne
29.02.2016
more
EMA confirms recommendations to minimise risk of brain infection PML with Tysabri
29.02.2016
more
EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes
29.02.2016
more
Measures for additional protection of patients from falsified medicinal products based on the Commission Delegated Regulation (EU) 2016/161 and plans for introduction of new safety features
19.02.2016
more
Notice of unavailability of HALMED's phone numbers
18.02.2016
more
